BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 29477370)

  • 1. The BMP pathway: A unique tool to decode the origin and progression of leukemia.
    Zylbersztejn F; Flores-Violante M; Voeltzel T; Nicolini FE; Lefort S; Maguer-Satta V
    Exp Hematol; 2018 May; 61():36-44. PubMed ID: 29477370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Single Cell Analysis of Leukemia Microenvironment Identifies Taurine-Taurine Transporter Axis as a Key Regulator of Myeloid Leukemia.
    Rodems BJ; Sharma S; Baker CD; Kaszuba CM; Ito T; Liesveld JL; Calvi LM; Becker MW; Jordan CT; Ashton JM; Bajaj J
    bioRxiv; 2024 May; ():. PubMed ID: 38798540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP signaling in cancer stemness and differentiation.
    Zhou W; Yan K; Xi Q
    Cell Regen; 2023 Dec; 12(1):37. PubMed ID: 38049682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new signaling cascade linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like human cell properties and patient outcome.
    Voeltzel T; Flores-Violante M; Zylbersztejn F; Lefort S; Billandon M; Jeanpierre S; Joly S; Fossard G; Milenkov M; Mazurier F; Nehme A; Belhabri A; Paubelle E; Thomas X; Michallet M; Louache F; Nicolini FE; Caron de Fromentel C; Maguer-Satta V
    Cell Death Dis; 2018 Sep; 9(10):1011. PubMed ID: 30262802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quiescent fraction of chronic myeloid leukemic stem cells depends on BMPR1B, Stat3 and BMP4-niche signals to persist in patients in remission.
    Jeanpierre S; Arizkane K; Thongjuea S; Grockowiak E; Geistlich K; Barral L; Voeltzel T; Guillemin A; Gonin-Giraud S; Gandrillon O; Nicolini FE; Mead AJ; Maguer-Satta V; Lefort S
    Haematologica; 2021 Jan; 106(1):111-122. PubMed ID: 32001529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the stem cell niche micro-environment as therapeutic strategies in aging.
    Farahzadi R; Valipour B; Montazersaheb S; Fathi E
    Front Cell Dev Biol; 2023; 11():1162136. PubMed ID: 37274742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation after mucosal injury and regeneration in ulcerative colitis.
    Zheng L; Duan SL; Wen XL; Dai YC
    Front Mol Biosci; 2022; 9():996057. PubMed ID: 36310594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-Action Icariin-Containing Thermosensitive Hydrogel for Wound Macrophage Polarization and Hair-Follicle Neogenesis.
    Teng YY; Zou ML; Liu SY; Jia Y; Zhang KW; Yuan ZD; Wu JJ; Ye JX; Yu S; Li X; Zhou XJ; Yuan FL
    Front Bioeng Biotechnol; 2022; 10():902894. PubMed ID: 35832407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Malignant Myeloid Leukemia by Mesenchymal Stem Cells.
    Tan Z; Kan C; Wong M; Sun M; Liu Y; Yang F; Wang S; Zheng H
    Front Cell Dev Biol; 2022; 10():857045. PubMed ID: 35756991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes.
    Fernández-Sevilla LM; Valencia J; Ortiz-Sánchez P; Fraile-Ramos A; Zuluaga P; Jiménez E; Sacedón R; Martínez-Sánchez MV; Jazbec J; Debeljak M; Fedders B; Stanulla M; Schewe D; Cario G; Minguela A; Ramírez M; Varas A; Vicente Á
    Blood; 2022 Jun; 139(22):3303-3313. PubMed ID: 35313334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer.
    Guyot B; Lefort S; Voeltzel T; Pécheur EI; Maguer-Satta V
    Front Cell Dev Biol; 2021; 9():787989. PubMed ID: 35047500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RW
    Lee H; Sun R; Niehrs C
    J Biol Chem; 2022 Feb; 298(2):101586. PubMed ID: 35032551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput measurements of bone morphogenetic protein/bone morphogenetic protein receptor interactions using biolayer interferometry.
    Khodr V; Machillot P; Migliorini E; Reiser JB; Picart C
    Biointerphases; 2021 Jun; 16(3):031001. PubMed ID: 34241280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling chromatin accessibility in pediatric acute lymphoblastic leukemia identifies subtype-specific chromatin landscapes and gene regulatory networks.
    Diedrich JD; Dong Q; Ferguson DC; Bergeron BP; Autry RJ; Qian M; Yang W; Smith C; Papizan JB; Connelly JP; Hagiwara K; Crews KR; Pruett-Miller SM; Pui CH; Yang JJ; Relling MV; Evans WE; Savic D
    Leukemia; 2021 Nov; 35(11):3078-3091. PubMed ID: 33714976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.
    Chang KC; Chen RY; Wang YC; Hung LY; Medeiros LJ; Chen YP; Chen TY; Yang JC; Chiang PM
    Sci Rep; 2020 Dec; 10(1):21342. PubMed ID: 33288848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R-spondins are BMP receptor antagonists in Xenopus early embryonic development.
    Lee H; Seidl C; Sun R; Glinka A; Niehrs C
    Nat Commun; 2020 Nov; 11(1):5570. PubMed ID: 33149137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Myeloid BMPR1a Alters Differentiation and Reduces Mouse Prostate Cancer Growth.
    Ihle CL; Straign DM; Provera MD; Novitskiy SV; Owens P
    Front Oncol; 2020; 10():357. PubMed ID: 32318332
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.